These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7153845

  • 1. Additive formation of antineoplastic 5-fluorouracil nucleosides from 5-fluorouracil by Ehrlich ascites tumor extracts in the presence of ribose 1-phosphate/uridine or deoxyribose 1-phosphate/deoxyuridine.
    Tamemasa O, Tezuka M.
    J Pharmacobiodyn; 1982 Sep; 5(9):720-6. PubMed ID: 7153845
    [Abstract] [Full Text] [Related]

  • 2. Increased formation of 5-fluoro-2'-deoxyuridine 5'-monophosphate from 5-fluorouracil in the presence of 2-deoxy-alpha-D-ribose 1-phosphate and 2'-deoxyuridine in Ehrlich ascites tumor cells.
    Tamemasa O, Tezuka M.
    Nucleic Acids Symp Ser; 1980 Sep; (8):s169-72. PubMed ID: 7255189
    [Abstract] [Full Text] [Related]

  • 3. Ribose-transfer activity from uridine to 5-fluorouracil in Ehrlich ascites tumor cells.
    Nabeya Y, Isono K, Moriyama Y, Fujimura S.
    Jpn J Cancer Res; 1990 Sep; 81(6-7):692-700. PubMed ID: 1698195
    [Abstract] [Full Text] [Related]

  • 4. Increased uptake of 5-fluorouracil by Ehrlich ascites tumor cells with some additives and metabolite analysis.
    Tezuka M, Chikaraishi Y, Tamemasa O.
    J Pharmacobiodyn; 1982 Nov; 5(11):893-9. PubMed ID: 6820043
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of potentiation of antitumor activity of 5-fluorouracil by ribothymidine in a mouse tumor system.
    Tezuka M, Chiba Y, Tamemasa O, Okada S.
    J Pharmacobiodyn; 1986 Dec; 9(12):962-9. PubMed ID: 3572717
    [Abstract] [Full Text] [Related]

  • 6. Antitumor effect of 5-fluorouracil in combination with some additives which stimulate the formation of antineoplastic 5-fluorouracil nucleotides.
    Tamemasa O, Tezuka M.
    Gan; 1983 Apr; 74(2):285-90. PubMed ID: 6407888
    [Abstract] [Full Text] [Related]

  • 7. Metabolism and biological activity of 5'-deoxy-5-fluorouridine, a novel fluoropyrimidine.
    Armstrong RD, Diasio RB.
    Cancer Res; 1980 Sep; 40(9):3333-8. PubMed ID: 6253060
    [Abstract] [Full Text] [Related]

  • 8. Ribose 1-phosphate metabolism in Ehrlich ascites tumor cells in vitro.
    Barankiewicz J, Henderson JF.
    Biochim Biophys Acta; 1977 Dec 14; 479(4):371-7. PubMed ID: 922006
    [Abstract] [Full Text] [Related]

  • 9. Distinguishing between membrane transport and intracellular metabolism of fluorodeoxyuridine in Ehrlich ascites tumor cells by application of kinetic and high performance liquid chromatographic techniques.
    Bowen D, Diasio RB, Goldman ID.
    J Biol Chem; 1979 Jun 25; 254(12):5333-9. PubMed ID: 156181
    [No Abstract] [Full Text] [Related]

  • 10. Antiglycolytic activities of 5-fluorouracil and related pyrimidines in mouse ascites carcinoma cells with special reference to inorganic phosphate and glucose.
    Woods MW, Burk D.
    Oncology; 1969 Jun 25; 23(1):1-32. PubMed ID: 5774952
    [No Abstract] [Full Text] [Related]

  • 11. Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines.
    el Kouni MH, el Kouni MM, Naguib FN.
    Cancer Res; 1993 Aug 15; 53(16):3687-93. PubMed ID: 8339277
    [Abstract] [Full Text] [Related]

  • 12. Relationship between antitumor effect and metabolites of 5-fluorouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system.
    Iigo M, Kuretani K, Hoshi A.
    Cancer Res; 1983 Dec 15; 43(12 Pt 1):5687-94. PubMed ID: 6640523
    [Abstract] [Full Text] [Related]

  • 13. Effects of hyperthermia on the metabolism of 5-fluorouracil in vitro.
    Maeta M, Sawata T, Kaibara N.
    Int J Hyperthermia; 1993 Dec 15; 9(1):105-13. PubMed ID: 8433020
    [Abstract] [Full Text] [Related]

  • 14. Homogeneous uridine kinase from Ehrlich ascites tumor: substrate specificity and inhibition by bisubstrate analogs.
    Cheng N, Payne RC, Kemp WE, Traut TW.
    Mol Pharmacol; 1986 Aug 15; 30(2):159-63. PubMed ID: 3016499
    [Abstract] [Full Text] [Related]

  • 15. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.
    Grem JL, Fischer PH.
    Cancer Res; 1986 Dec 15; 46(12 Pt 1):6191-9. PubMed ID: 2946402
    [Abstract] [Full Text] [Related]

  • 16. Stimulatory effects of inosine and deoxyinosine on the incorporation of uracil-2-14-C, 5-fluorouracil-2-14-C, and 5-bromouracil-2-14-C into nucleic acids by Ehrlich ascites tumor cells in vitro.
    Gotto AM, Belkhode ML, Touster O.
    Cancer Res; 1969 Apr 15; 29(4):807-11. PubMed ID: 5775710
    [No Abstract] [Full Text] [Related]

  • 17. Studies on 18F-labeled pyrimidines. II. Metabolic investigation of 18F-5-fluorouracil, 18F-5-fluoro-2'-deoxyuridine and 18F-5-fluorouridine in rats.
    Ishiwata K, Ido T, Kawashima K, Murakami M, Takahashi T.
    Eur J Nucl Med; 1984 Apr 15; 9(4):185-9. PubMed ID: 6232143
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of antitumor activity of 5-fluorouracil by ribothymidine.
    Tezuka M, Chiba Y, Okada S, Tamemasa O.
    J Pharmacobiodyn; 1986 Aug 15; 9(8):683-7. PubMed ID: 3783412
    [Abstract] [Full Text] [Related]

  • 19. Specificity of pyrimidine nucleoside phosphorylases and the phosphorolysis of 5-fluoro-2'-deoxyuridine.
    Woodman PW, Sarrif AM, Heidelberger C.
    Cancer Res; 1980 Mar 15; 40(3):507-11. PubMed ID: 6451286
    [Abstract] [Full Text] [Related]

  • 20. Detection of differential sensitivity to 5-fluorouracil in Ehrlich ascites tumour cells by 19F NMR spectroscopy.
    McSheehy PM, Maxwell RJ, Griffiths JR.
    NMR Biomed; 1991 Dec 15; 4(6):274-8. PubMed ID: 1667850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.